BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDP
2151
DELISTED
Meredith Corporation
MDP
| $69.5K | ﹤0.01% |
4,775
-1,926
| -29% | -$28K |
|
2152
Viking Therapeutics
VKTX
$2.79B
| $69.2K | ﹤0.01% |
9,599
-32,251
| -77% | -$233K |
|
|
INN
2153
Summit Hotel Properties
INN
$623M
| $69K | ﹤0.01% |
11,631
-31,048
| -73% | -$184K |
|
|
MAXR
2154
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $69K | ﹤0.01% |
3,840
-15,979
| -81% | -$287K |
|
2155
ProShares Ultra S&P500
SSO
$7.39B
| $68.8K | ﹤0.01% |
+2,200
| New | +$68.8K |
|
2156
AtriCure
ATRC
$1.74B
| $68.7K | ﹤0.01% |
1,528
-10,244
| -87% | -$460K |
|
2157
Amkor Technology
AMKR
$6.29B
| $68.6K | ﹤0.01% |
5,570
-95,979
| -95% | -$1.18M |
|
2158
Gossamer Bio
GOSS
$787M
| $68.6K | ﹤0.01% |
5,274
-16,771
| -76% | -$218K |
|
2159
Silicon Motion
SIMO
$3.02B
| $68.3K | ﹤0.01% |
+1,400
| New | +$68.3K |
|
2160
Oxford Industries
OXM
$701M
| $67.6K | ﹤0.01% |
1,537
-5,522
| -78% | -$243K |
|
2161
Scholastic
SCHL
$691M
| $67.5K | ﹤0.01% |
2,253
-10,139
| -82% | -$304K |
|
|
VSTO
2162
DELISTED
Vista Outdoor Inc.
VSTO
| $67.3K | ﹤0.01% |
4,660
-343,438
| -99% | -$4.96M |
|
|
RWT
2163
Redwood Trust
RWT
$804M
| $67.3K | ﹤0.01% |
9,612
-37,603
| -80% | -$263K |
|
|
RPT
2164
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $67.2K | ﹤0.01% |
9,661
-24,325
| -72% | -$169K |
|
2165
National Bank Holdings
NBHC
$1.46B
| $67K | ﹤0.01% |
2,481
-10,154
| -80% | -$274K |
|
2166
Guess, Inc.
GES
$869M
| $66.9K | ﹤0.01% |
6,921
-95,883
| -93% | -$927K |
|
2167
AMERISAFE
AMSF
$841M
| $66.7K | ﹤0.01% |
1,091
-6,511
| -86% | -$398K |
|
2168
TriMas Corp
TRS
$1.59B
| $66.4K | ﹤0.01% |
2,773
-12,096
| -81% | -$290K |
|
|
BPMP
2169
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $66.1K | ﹤0.01% |
5,762
-323
| -5% | -$3.71K |
|
2170
Park National Corp
PRK
$2.72B
| $66K | ﹤0.01% |
938
-3,500
| -79% | -$246K |
|
|
KNOW
2171
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
| $65.8K | ﹤0.01% |
2,000
| – | – |
|
2172
Stride
LRN
$6.91B
| $65.6K | ﹤0.01% |
2,407
-10,720
| -82% | -$292K |
|
2173
Kura Oncology
KURA
$711M
| $65.2K | ﹤0.01% |
3,998
-10,194
| -72% | -$166K |
|
|
BMCH
2174
DELISTED
BMC Stock Holdings, Inc
BMCH
| $65.2K | ﹤0.01% |
2,592
-22,587
| -90% | -$568K |
|
|
FLXN
2175
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $65K | ﹤0.01% |
4,941
-14,671
| -75% | -$193K |
|